Lv3
230 积分 2022-10-13 加入
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
11小时前
待确认
Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma
11小时前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
11小时前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
12小时前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
15小时前
已完结
p16 Ink4a ‐Positive Hepatocytes Drive Liver Fibrosis Through Activation of LIFR Family Pathway
28天前
已完结
Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion
2个月前
已完结
SPP1+ macrophages polarized by lactate confer the progression of hypoxic adaptive tumor cells in brain
2个月前
已完结
A traditional Chinese medicine prescription recommendation model based on contrastive pre-training and hierarchical structure network
2个月前
已完结
Targeting PYK2 with heterobifunctional T6BP helps mitigate MASLD and MASH-HCC progression
2个月前
已完结
皖公网安备34019202002308
